Table 5.
Reviews on application of nanoparticle vaccine delivery systems.
| Title | Reference |
|---|---|
| Nanoparticles and microparticles as vaccine-delivery systems | [213] |
| Implication of nanoparticles/microparticles in mucosal vaccine delivery | [214] |
| The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery | [215] |
| Vaccine delivery—current trends and future | [216] |
| Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems | [217] |
| Nanoparticles as carriers for nasal vaccine delivery | [110] |
| Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens | [218] |
| DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells | [130] |
| Immunological aspects of polymer microsphere vaccine delivery systems | [219] |
| Microparticles as vaccine adjuvants and delivery systems | [168] |
| Recent developments in vaccine delivery systems | [166] |
| Recent advances in vaccine adjuvants | [167] |
| Microparticle vaccine approaches to stimulate mucosal immunisation | [220] |
| Chitosan and its derivatives in mucosal drug and vaccine delivery | [221] |
| Nanoparticles and microparticles for drug and vaccine delivery | [96] |